India's Boardrooms Have Stopped Playing Defence — Has Your Strategy Caught Up?

For decades, India's boardrooms debated how to attract foreign capital. In the second quarter of 2026, they quietly flipped the script.

India's total deal value reached $36.3 billion in Q2 2026 — a 127% surge over the previous quarter and a four-year high, according to Grant Thornton's Dealtracker report. The number is striking. The reason behind it is more so: outbound acquisitions accounted for 84% of that value. Indian companies are no longer primarily attracting investment; they are making it, aggressively and at scale, across continents.

The centrepiece was Sun Pharmaceutical Industries' $11.75 billion acquisition of Organon — the largest overseas acquisition in the history of Indian pharma, and the biggest biopharma deal globally in 2026. All five of the quarter's billion-dollar transactions were cross-border. Every single one was an Indian company going out to buy something the world had.

This is not a moment for financial analysts alone. It is a strategy conversation. And most Indian executives have not yet had it.

The old growth playbook — build capacity, wait for scale, expand gradually — is being abandoned by a generation of leaders who have run out of patience.

Consider what outbound M&A actually buys: it is not just revenue or market share. It is time. When Sun Pharma acquires Organon, it purchases women's health distribution networks, regulatory approvals, biosimilar pipelines, and commercial presence across developed markets. Building those organically would take fifteen years. The acquisition compresses that to three.

The same logic applies across sectors. Indian technology firms acquiring European software companies are buying product intellectual property. Chemicals companies acquiring niche German manufacturers are buying precision engineering capability. The strategic intent is consistent: fill gaps that organic growth cannot close quickly enough.

Reinforcing this, the Reserve Bank of India introduced a new financing framework effective July 2026 — for the first time allowing Indian banks to fund up to 75% of an acquisition's value. The structural barriers to outbound M&A are falling away, one by one.

For CXOs still treating M&A as a financial option rather than a strategic tool, this moment demands an uncomfortable question: what capabilities does your organisation need in three years that you cannot build fast enough on your own?

However, the evidence on M&A outcomes is sobering — and this is precisely where the strategic conversation must deepen.

Research consistently places the failure rate for acquisitions between 70% and 90%. The reasons are well-documented: cultural misalignment, unclear accountability post-close, leadership uncertainty, and the systematic underestimation of how long integration actually takes. Cross-border deals add another layer entirely — crossing not just organisational but also national, linguistic, and regulatory boundaries simultaneously.

McKinsey's research on this is unambiguous: companies that manage culture effectively during integration are approximately 50% more likely to meet or exceed their synergy targets. Yet integration planning remains one of the most under-resourced phases of any M&A process. Leaders celebrate the deal announcement; far fewer invest equivalent energy in what happens the morning after close.

This does not mean Indian companies should hesitate. It means they must prepare. The companies that consistently derive value from M&A treat integration as a strategic priority — not a post-deal administrative task. They appoint dedicated integration leadership before the deal signs. They make hard decisions about talent quickly and communicate repeatedly with the acquired organisation. They define success metrics at the outset and track them rigorously.

The speed and ambition of India's current outbound push is genuinely impressive. The open question is whether the integration capabilities of Indian acquirers are growing at the same pace as their acquisition appetite.

The strategic inflection point is real — and it requires a response not from investment bankers, but from boards and senior leadership teams.

The conversation that most Indian organisations have not yet had is this: what is our acquisition strategy, and do we have the organisational muscle to execute it well? This is not a question reserved for large conglomerates. Mid-sized Indian companies with strong sectoral positions are increasingly well-placed to acquire niche overseas players, particularly in markets where Indian operational expertise and cost discipline represent genuine competitive advantages.

Build the capability before you need it. That means developing internal M&A expertise, establishing a clear thesis about which capabilities are worth acquiring, and investing in integration leadership well before any deal is signed. Companies that build this muscle in calm water are the ones that integrate well under pressure.

India's boardrooms have stopped playing defence. The real question is whether your growth strategy has caught pace — or whether you are still waiting for the world to come to you.